| Code | 7098A | ||||||||||
| MA number | 29/0364/13-S | ||||||||||
| Product Form: | tbl flm 100x400 mg (fľ.HDPE-dávk.balenie) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Viatris Limited, Ireland | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 25.09.2013 |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Brufedol Rapid 400 mg_10 2024.pdf
|
| PIL: |
PIL_Brufedol Rapid 400 mg_10.2024.pdf
|
| Safety feature | Yes |
| Data update: | 03.02.2020 |
